Marktgröße und Marktanteil von Therapeutika gegen sexuelle Luststörungen bei Frauen bis 2025 – 2031
Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis
Female Hypoactive Sexual Desire Disorder Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Allergan plc
- AMAG Pharmaceuticals, Inc.
- Emotional Brain BV
- Endoceutics, Inc.
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Palatin Technologies Inc
- Pivot Pharmaceuticals Inc
- Sprout Pharmaceuticals, Inc.
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Therapie
- Testosteron
- Flibanserin
- Buspiron
- Bupropion
- Bremelanotid
- kognitive Verhaltenstherapie
By Anmeldung
- stationär
- ambulant
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For